VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
XOMAXOMA Royalty Corp.
$41.89$525M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. XOMA
  3. Financial Ratios

XOMA Royalty Corp. (XOMA) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Biotechnology

View Quarterly Ratios →

P/E Ratio
↓
28.69
+14% vs avg
5yr avg: 25.14
020%ile100
30Y Low18.2·High56.6
View P/E History →
EV/EBITDA
↑
39.98
↑+75% vs avg
5yr avg: 22.90
0100%ile100
30Y Low5.5·High36.7
P/FCF
182.98
+10% vs avg
5yr avg: 166.54
0100%ile100
30Y Low16.6·High166.5
P/B Ratio
↑
7.25
↑+155% vs avg
5yr avg: 2.85
078%ile100
30Y Low1.7·High133.6
ROE
↑
34.1%
↓+975% vs avg
5yr avg: -3.9%
094%ile100
30Y Low-390%·High252%
Debt/EBITDA
↑
9.16
↑+100% vs avg
5yr avg: 4.59
083%ile100
30Y Low0.0·High12.1

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

XOMA Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

XOMA Royalty Corp. trades at 28.7x earnings, 14% above its 5-year average of 25.1x, sitting at the 20th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 30%. On a free-cash-flow basis, the stock trades at 183.0x P/FCF, 10% above the 5-year average of 166.5x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$525M$478M$308M$212M$210M$254M$508M$239M$106M$284M$25M
Enterprise Value$574M$527M$325M$183M$152M$161M$445M$215M$83M$255M$43M
P/E Ratio →28.6918.21———32.0856.58——48.77—
P/S Ratio10.079.1710.7944.6034.846.6617.2813.0219.995.394.57
P/B Ratio7.254.603.752.391.691.795.875.445.6449.10—
P/FCF182.98166.54————57.15——106.08—
P/OCF182.98166.54———11.2150.30——105.77—

P/E links to full P/E history page with 30-year chart

XOMA EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

XOMA Royalty Corp.'s enterprise value stands at 40.0x EBITDA, 75% above its 5-year average of 22.9x. The Healthcare sector median is 14.2x, placing the stock at a 181% premium on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—10.1011.4138.5425.254.2215.1311.7315.594.847.70
EV / EBITDA39.9836.69———9.1035.32——14.72—
EV / EBIT50.4211.75———9.8532.60——14.59—
EV / FCF—183.49————50.06——95.29—

XOMA Profitability

Margins and return-on-capital ratios measuring operating efficiency

XOMA Royalty Corp. earns an operating margin of 21.8%. Operating margins have expanded from -879.5% to 21.8% over the past 3 years, signaling improving operational efficiency. Return on equity of 34.1% is exceptionally high. ROIC of 6.8% represents adequate returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin94.3%94.3%99.3%97.0%95.5%99.6%99.4%93.2%68.3%85.1%74.8%
Operating Margin21.8%21.8%-140.3%-879.5%-288.9%45.9%42.3%-21.1%-318.1%32.3%-1106.4%
Net Profit Margin60.8%60.8%-48.5%-858.2%-283.8%41.4%45.3%-10.8%-251.8%27.7%-962.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE34.1%34.1%-16.2%-38.4%-12.9%13.8%20.4%-6.3%-108.6%252.3%—
ROA12.8%12.8%-6.1%-21.8%-11.1%10.8%12.0%-2.5%-24.5%39.7%-103.4%
ROIC6.8%6.8%-37.6%-49.8%-22.7%36.4%42.7%-37.3%———
ROCE5.2%5.2%-19.4%-24.0%-12.1%13.2%12.4%-5.4%-35.3%101.1%-257.8%

XOMA Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

XOMA Royalty Corp. carries a Debt/EBITDA ratio of 9.2x, which is highly leveraged (185% above the sector average of 3.2x). Net debt stands at $49M ($132M total debt minus $83M cash). Interest coverage of 3.4x is adequate, though a cyclical earnings downturn could tighten the margin of safety.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity1.271.271.461.400.000.000.250.751.202.52—
Debt / EBITDA9.169.16———0.011.69——0.84—
Net Debt / Equity—0.470.21-0.33-0.47-0.66-0.73-0.54-1.24-4.99—
Net Debt / EBITDA3.393.39———-5.26-5.00——-1.67—
Debt / FCF—16.94————-7.09——-10.79—
Interest Coverage3.443.44-0.41-41.24—35.477.40-2.02-13.6214.13-12.57

XOMA Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

XOMA Royalty Corp.'s current ratio of 3.37x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 8.68x to 3.37x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.373.375.158.688.987.487.166.768.355.950.84
Quick Ratio3.373.375.158.688.987.487.036.768.355.950.84
Cash Ratio2.392.394.327.878.537.266.856.398.035.860.79
Asset Turnover—0.190.130.020.040.230.230.190.081.170.19
Inventory Turnover——————0.11————
Days Sales Outstanding—34.27218.011167.49143.352.0022.2258.28101.122.7537.13

XOMA Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

XOMA Royalty Corp. returns 3.8% to shareholders annually — split between a 0.7% dividend yield and 3.1% buyback yield. The earnings yield of 3.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield0.7%1.1%1.8%2.6%2.6%1.4%—————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield3.5%5.5%———3.1%1.8%——2.1%—
FCF Yield0.5%0.6%————1.7%——0.9%—
Buyback Yield3.1%3.4%0.0%0.1%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Total Shareholder Yield3.8%4.5%1.8%2.6%2.6%1.4%0.0%0.0%0.0%0.0%0.0%
Shares Outstanding—$18M$12M$11M$11M$12M$12M$9M$8M$8M$6M

Peer Comparison

Compare XOMA with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
XOMA logoXOMAYou$525M28.740.0183.094.3%21.8%34.1%6.8%9.2
RPRX logoRPRX$23B29.419.89.1100.0%65.6%7.7%6.7%5.7
BCYC logoBCYC$277M-1.3——100.0%-341.3%-31.2%——
OMAB logoOMAB$6B17.910.813.075.6%56.0%48.6%31.7%1.4
RCUS logoRCUS$2B-7.4——96.0%-156.3%-63.3%-64.1%—
NUVL logoNUVL$9B-21.1————-36.7%-32.5%—
PRAX logoPRAX$8B-20.9————-45.8%-65.0%—
PFE logoPFE$143B18.510.315.870.3%24.7%8.9%7.5%3.3
MRK logoMRK$281B15.610.822.872.0%36.2%36.9%22.0%1.7
ABBV logoABBV$383B91.415.821.570.2%32.8%6214.7%23.9%2.4
BMY logoBMY$110B15.78.98.667.6%26.3%40.4%16.9%2.8
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XOMA — Frequently Asked Questions

Quick answers to the most common questions about buying XOMA stock.

What is XOMA Royalty Corp.'s P/E ratio?

XOMA Royalty Corp.'s current P/E ratio is 28.7x. The historical average is 41.8x. This places it at the 20th percentile of its historical range.

What is XOMA Royalty Corp.'s EV/EBITDA?

XOMA Royalty Corp.'s current EV/EBITDA is 40.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.3x.

What is XOMA Royalty Corp.'s ROE?

XOMA Royalty Corp.'s return on equity (ROE) is 34.1%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -89.1%.

Is XOMA stock overvalued?

Based on historical data, XOMA Royalty Corp. is trading at a P/E of 28.7x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is XOMA Royalty Corp.'s dividend yield?

XOMA Royalty Corp.'s current dividend yield is 0.73%.

What are XOMA Royalty Corp.'s profit margins?

XOMA Royalty Corp. has 94.3% gross margin and 21.8% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does XOMA Royalty Corp. have?

XOMA Royalty Corp.'s Debt/EBITDA ratio is 9.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.